These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1409614)

  • 41. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel class II-binding motif selects peptides that mediate organ-specific autoimmune disease in SWXJ, SJL/J, and SWR/J mice.
    Jane-wit D; Yu M; Edling AE; Kataoka S; Johnson JM; Stull LB; Moravec CS; Tuohy VK
    J Immunol; 2002 Dec; 169(11):6507-14. PubMed ID: 12444161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of class II major histocompatibility complex molecules on thyrocytes does not cause spontaneous thyroiditis but mildly increases its severity after immunization.
    Kimura H; Kimura M; Tzou SC; Chen YC; Suzuki K; Rose NR; Caturegli P
    Endocrinology; 2005 Mar; 146(3):1154-62. PubMed ID: 15591134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
    Tran CN; Davis MJ; Tesmer LA; Endres JL; Motyl CD; Smuda C; Somers EC; Chung KC; Urquhart AG; Lundy SK; Kovats S; Fox DA
    Arthritis Rheum; 2007 May; 56(5):1497-506. PubMed ID: 17469112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-class II MHC antibodies prevent and treat EAE without APC depletion.
    Smith RM; Morgan A; Wraith DC
    Immunology; 1994 Sep; 83(1):1-8. PubMed ID: 7821954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity.
    Liao L; Sindhwani R; Rojkind M; Factor S; Leinwand L; Diamond B
    J Exp Med; 1995 Mar; 181(3):1123-31. PubMed ID: 7869033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin.
    Wang Y; Afanasyeva M; Hill SL; Rose NR
    Autoimmunity; 1999; 31(3):151-62. PubMed ID: 10739332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac alpha-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes.
    Liao L; Sindhwani R; Leinwand L; Diamond B; Factor S
    J Clin Invest; 1993 Dec; 92(6):2877-82. PubMed ID: 7504694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen presentation by cells that are not of bone marrow origin.
    Geppert TD; Lipsky PE
    Reg Immunol; 1989; 2(1):60-71. PubMed ID: 2518360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J mice.
    Massilamany C; Gangaplara A; Basavalingappa RH; Rajasekaran RA; Khalilzad-Sharghi V; Han Z; Othman S; Steffen D; Reddy J
    Int J Cardiol; 2016 Jan; 202():311-21. PubMed ID: 26422020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides.
    Wegmann KW; Zhao W; Griffin AC; Hickey WF
    J Immunol; 1994 Jul; 153(2):892-900. PubMed ID: 8021520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen.
    Volkmann A; Zal T; Stockinger B
    J Immunol; 1997 Jan; 158(2):693-706. PubMed ID: 8992985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct evidence for functional self-protein/Ia-molecule complexes in vivo.
    Lorenz RG; Allen PM
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5220-3. PubMed ID: 2839836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis.
    Neumann DA; Lane JR; Wulff SM; Allen GS; LaFond-Walker A; Herskowitz A; Rose NR
    J Immunol; 1992 Jun; 148(12):3806-13. PubMed ID: 1602130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transgenic mice producing major histocompatibility complex class II molecules on thyroid cells do not develop apparent autoimmune thyroid diseases.
    Li YS; Kanamoto N; Hataya Y; Moriyama K; Hiratani H; Nakao K; Akamizu T
    Endocrinology; 2004 May; 145(5):2524-30. PubMed ID: 14764636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoimmune myocarditis.
    Smith SC
    Curr Protoc Immunol; 2001 May; Chapter 15():Unit 15.14. PubMed ID: 18432731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.